NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CHEK

Check-Cap Ltd

Jul 02 • 04:00PM ET

0.7522

Dollar change -0.0078
Percentage change -1.03	%

Healthcare • Diagnostics & Research • Israel • NASD

Peers: EXAS GH NTRA CDNA MYGN FLGT BNGO OCGN

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	25.06%	Shs Outstand	5.85M	Perf Week	-2.31%
Market Cap	4.40M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.38M	Perf Month	-6.15%
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	1.59%	Short Float	0.45%	Perf Quarter	-5.98%
Income	-	P/S	-	EPS this Y	-	Inst Trans	-28.91%	Short Ratio	0.26	Perf Half Y	-31.62%
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.02M	Perf YTD	-24.01%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	3.04 -75.26%	Perf Year	-62.58%
Cash/sh	-	P/FCF	-	EPS past 3/5Y	30.95% 43.50%	ROIC	-	52W Low	0.56 34.32%	Perf 3Y	-88.67%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	4.81% 3.92%	Perf 5Y	-93.07%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-99.93%
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	44.01	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	23.42%	SMA20	-2.61%	Beta	0.22	Target Price	7.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-6.76%	Rel Volume	0.07	Prev Close	0.76
Employees	-	LT Debt/Eq	-	Earnings	-	SMA200	-23.27%	Avg Volume	76.50K	Price	0.75
IPO	Mar 18, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	46.99% -	Trades		Volume	5,144	Change	-1.03%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-19	Initiated	Dawson James	Buy
Jan-11-18	Reiterated	H.C. Wainwright	Buy	$5.50 → $6
Nov-28-17	Reiterated	H.C. Wainwright	Buy	$7 → $5.50
Sep-28-17	Reiterated	H.C. Wainwright	Buy	$6 → $7
Jan-19-17	Initiated	Rodman & Renshaw	Buy	$6
Aug-01-16	Reiterated	Maxim Group	Buy	$11 → $6
May-20-16	Reiterated	Chardan Capital Markets	Buy	$6 → $4
Mar-16-16	Reiterated	Chardan Capital Markets	Buy	$7.75 → $6
Jan-19-16	Reiterated	Maxim Group	Buy	$18 → $11
Oct-09-15	Initiated	Maxim Group	Buy	$18
Jul-22-15	Reiterated	Chardan Capital Markets	Buy	$9 → $7.75
May-01-15	Initiated	Chardan Capital Markets	Buy	$9

Show Previous Ratings

Jun-04-25 07:00AM	Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime (GlobeNewswire)
May-14-25 08:30AM	Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders (PR Newswire) +8.30%
May-08-25 07:30AM	Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction (PR Newswire) -10.20%
May-31-24 01:53PM	CHEK Stock Earnings: Check-Cap Beats EPS for Q4 2023 (InvestorPlace)
Mar-26-24 08:35AM	Why Is Check-Cap (CHEK) Stock Up 44% Today? (InvestorPlace) +25.70%
07:37PM	Loading…
Mar-25-24 07:37PM	Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement (PR Newswire)
Dec-22-23 10:36AM	SYMETRYX COMMENTS ON SUCCESSFUL CAMPAIGN AT CHECK-CAP LTD (PR Newswire) +8.70%
Dec-14-23 07:13PM	Check-Cap Board of Directors Issues Letter to Shareholders (GlobeNewswire) -5.34%
Dec-13-23 12:37PM	CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL (PR Newswire)
Dec-08-23 11:18AM	CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES (PR Newswire)
Dec-07-23 01:54PM	Leading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination Agreement (GlobeNewswire)
Dec-05-23 03:42PM	CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER AND FOR THE SYMETRYX BOARD OF DIRECTORS NOMINEES (PR Newswire) -7.77%
Nov-28-23 11:56AM	Symetryx Today Issues Open Letter to Shareholders In Regard to the Upcoming Annual General Meeting (PR Newswire)
11:42AM	Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update (GlobeNewswire)
Nov-27-23 08:00AM	Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update (PR Newswire) -7.76%
04:05PM	Loading…
Nov-13-23 04:05PM	Keystone Dental Announces Launch of the GENESIS ACTIVE Dental Implant System: Revolutionizing Dental Implantology (GlobeNewswire)
Nov-06-23 08:00AM	Keystone Dental Announces Market Launch of Nexus Connect, the First A.I. Enabled Intraoral Implant-Scan Analyzer for the Nexus iOS Full-Arch Solution (GlobeNewswire)
Oct-31-23 06:39PM	Notice of Extraordinary General Meeting of Shareholders (GlobeNewswire)
Oct-19-23 07:33PM	Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings (GlobeNewswire)
Oct-18-23 04:05PM	Keystone Dental Group Granted Patent from USPTO for Nexus IOS Solution (GlobeNewswire)
Sep-21-23 03:25PM	SYMETRYX OPPOSES CHEK CAP/KEYSTONE MERGER, WILL EVALUATE OPTIONS TO STOP TRANSACTION (PR Newswire) +6.02%
Aug-16-23 05:08PM	Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement (GlobeNewswire) -23.70%
Aug-04-23 04:15PM	Check-Cap Reports Second Quarter 2023 Financial Results (PR Newswire)
Jul-25-23 10:22AM	SYMETRYX CORP INCREASES NON-BINDING OFFER TO ACQUIRE CHECK-CAP TO $4.60 PER SHARE (PR Newswire) +8.22%
Jun-06-23 07:00AM	Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce (PR Newswire) +6.70%
May-11-23 04:30PM	Check-Cap Reports First Quarter 2023 Financial Results (PR Newswire) -22.28%
Mar-31-23 04:45PM	Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) -6.29%
Mar-21-23 12:04PM	Why Are Check-Cap Shares Plummeting Today? (Benzinga) -42.24%
09:00AM	Check-Cap Issues an Update to Shareholders (PR Newswire)
Nov-30-22 08:30AM	Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update (PR Newswire) +17.69%
08:00AM	Loading…
Aug-31-22 08:00AM	Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update (PR Newswire) -20.45%
Jun-23-22 08:30AM	Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement (PR Newswire)
Jun-06-22 01:33PM	We're Hopeful That Check-Cap (NASDAQ:CHEK) Will Use Its Cash Wisely (Simply Wall St.)
Jun-01-22 08:00AM	Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update (PR Newswire)
May-11-22 08:00AM	Check-Cap Announces Initiation of the U.S. Pivotal Trial (PR Newswire)
Apr-07-22 08:30AM	Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results (PR Newswire)
Mar-01-22 08:30AM	Check-Cap Ltd. Announces $10 Million Registered Direct Offering (PR Newswire) -37.01%
Feb-07-22 08:30AM	Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan (PR Newswire) +11.72%
Jan-05-22 09:15AM	Check-Cap Issues Letter to Shareholders (PR Newswire)
Dec-28-21 05:26AM	Companies Like Check-Cap (NASDAQ:CHEK) Are In A Position To Invest In Growth (Simply Wall St.) -5.56%
Dec-23-21 04:15PM	Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire) -5.10%
Nov-22-21 08:00AM	Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan® (PR Newswire) -5.29%
Nov-03-21 08:30AM	Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update (PR Newswire) -7.21%
Nov-02-21 08:30AM	Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories (PR Newswire) +19.02%
Oct-18-21 08:00AM	Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation (PR Newswire)
Sep-01-21 08:30AM	Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs (PR Newswire)
Aug-05-21 08:30AM	Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update (PR Newswire)
Jul-01-21 02:12AM	We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth (Simply Wall St.)
Jun-30-21 11:32AM	Check-Cap Shares Are Trading Lower On Capital Raise Of $35M To Support C-Scan Development (Benzinga) -15.23%
08:12AM	Check-Cap Ltd. Announces $35 Million Registered Direct Offering (PR Newswire)
Jun-19-21 04:45AM	Cognizant Technology Solutions (NASDAQ:CTSH) Has A Pretty Healthy Balance Sheet (Simply Wall St.)
May-12-21 08:00AM	Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update (PR Newswire) -6.94%
Mar-19-21 07:00AM	Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results (PR Newswire) +5.39%
Mar-15-21 07:00AM	Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan® (PR Newswire) +100.65%
06:07AM	Check-Cap Doubles; FDA OKs Request to Study Polyp-Detection Test (TheStreet.com)
Jan-27-21 08:30AM	Check-Cap Issues Letter to Shareholders (PR Newswire) -10.56%
Jan-02-21 01:43AM	Is Check-Cap (NASDAQ:CHEK) In A Good Position To Invest In Growth? (Simply Wall St.)
Nov-18-20 08:00AM	Check-Cap Reports Third Quarter 2020 Financial Results and Corporate Highlights (PR Newswire) +8.35%
Aug-06-20 08:00AM	Check-Cap Reports Second Quarter 2020 Financial Results and Corporate Highlights (PR Newswire)
Jul-23-20 09:35AM	Check-Cap Announces Exercise of Warrants For $9.6 Million Gross Proceeds (PR Newswire) -20.01%
Jun-07-20 08:01AM	We're A Little Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Rate (Simply Wall St.)
Jun-05-20 04:05PM	Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire)
May-27-20 04:45PM	Check-Cap Reports First Quarter 2020 Financial Results and Provides Corporate Update (PR Newswire)
May-08-20 09:31PM	Check-Cap Ltd. Announces $3.0 Million Registered Direct Offering (PR Newswire)
Apr-30-20 09:00AM	Check-Cap Ltd. Announces $4.5 Million Registered Direct Offering (PR Newswire) -14.29%
Apr-20-20 08:45AM	Check-Cap Ltd. Announces $4.0 Million Registered Direct Offering (PR Newswire) -46.12%
Apr-16-20 12:00PM	Check-Cap Ltd. (CHEK) Upgraded to Buy: What Does It Mean for the Stock? (Zacks) -9.81%
Apr-06-20 08:12AM	Check-Cap Provides Update on COVID-19 Pandemic Impact on Operational and Clinical Activities (PR Newswire) -14.42%
Mar-12-20 12:00PM	Check-Cap Ltd. (CHEK) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-06-20 08:00AM	Check-Cap Reports Fourth Quarter and Full Year 2019 Financial Results (PR Newswire) -7.24%
Dec-30-19 06:30AM	Check-Cap Announces Positive Results from U.S. Pilot Study of C-Scan® System (PR Newswire)
Dec-23-19 10:26AM	Is Check-Cap Ltd. (CHEK) Going To Burn These Hedge Funds ? (Insider Monkey)
Dec-20-19 07:00AM	Check-Cap Announces $4.75 Million Private Placement (PR Newswire)
Nov-11-19 08:48AM	What Kind Of Shareholder Owns Most Check-Cap Ltd. (NASDAQ:CHEK) Stock? (Simply Wall St.) -5.15%
Nov-06-19 08:30AM	Check-Cap Reports Third Quarter 2019 Financial Results and Corporate Highlights (PR Newswire)
Oct-24-19 04:30PM	Check-Cap to Present at the Dawson James 5th Annual Small Cap Growth Conference (PR Newswire) +12.07%
Sep-25-19 08:34AM	Check-Cap Expands Leadership Team With Appointment of Dr. Vardit Segal as Vice President of Clinical Affairs (PR Newswire)
Sep-03-19 08:00AM	Check-Cap to Present at the H.C. Wainwright 21st Annual Global Investment Conference (PR Newswire)
Aug-19-19 06:30AM	Check-Cap and GE Healthcare Announce Completion of Manufacturing Line Transfer Implementation and Qualification for the C-Scan® System Operated by GE Healthcare (PR Newswire)
Aug-07-19 08:00AM	Check-Cap Reports Second Quarter 2019 Financial Results and Corporate Highlights (PR Newswire)
Jul-09-19 06:30AM	Check-Cap Announces Positive Final Results from Its Post-CE Approval Study of the C-Scan® System (PR Newswire)
Jun-03-19 07:00AM	Check-Cap Appoints Joshua (Shuki) Belkar as Vice President of Operations (PR Newswire)
May-16-19 07:30AM	Check-Cap to Present Data at Digestive Disease Week® Demonstrating Substantial Improvement in Precancerous Polyp Detection (PR Newswire) +5.56%
May-13-19 08:00AM	Check-Cap Reports First Quarter 2019 Financial Results (PR Newswire)
07:30AM	Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan® (PR Newswire)
Apr-08-19 07:30AM	Check-Cap Initiates U.S. Pilot Study of C-Scan® for Colorectal Cancer Screening (PR Newswire)
Mar-28-19 05:00PM	Check-Cap Reports Fourth Quarter and Full-Year 2018 Financial Results (PR Newswire)
Mar-18-19 08:20AM	Check-Cap Announces Appointment of Mira Rosenzweig as Chief Financial Officer (PR Newswire)
Feb-12-19 07:00AM	Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan® (PR Newswire)
Feb-07-19 12:30PM	Check-Cap Ltd. Announces Closing of $7.5 Million Registered Direct Offering (PR Newswire)
Feb-04-19 07:40AM	Check-Cap Ltd. Announces $7.5 Million Registered Direct Offering (PR Newswire) -27.62%
Dec-13-18 07:00AM	Check-Cap Announces FDA Conditional Approval of IDE to Initiate U.S. Pilot Study of C-Scan® (PR Newswire)
Nov-13-18 08:50AM	Analysis: Positioning to Benefit within Autoliv, Science Applications International, Trecora Resources, Ardmore Shipping, Check-Cap, and Sharps Compliance Research Highlights Growth, Revenue, and Consolidated Results (GlobeNewswire) -5.41%
Nov-05-18 06:53AM	Check-Cap Reports Third Quarter 2018 Financial Results (PR Newswire)
Oct-09-18 07:00AM	Check-Cap Announces IDE Submission to FDA for Its C-Scan® System (PR Newswire)
Sep-05-18 07:00AM	Check-Cap Receives Approval From the Israeli Ministry of Health to Initiate Commercial Sales in Israel of its C-Scan® System (PR Newswire)
Sep-04-18 07:00AM	Check-Cap Announces Promising Interim Results from its Ongoing Post-CE Approval Study of C-Scan® System Version 3 (PR Newswire)
Aug-29-18 08:00AM	Check-Cap Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference (PR Newswire) +5.79%
Jul-31-18 07:00AM	Check-Cap Reports Second Quarter 2018 Financial Results (PR Newswire) +16.05%
Jul-12-18 07:25AM	Free Research Reports on DexCom and Three More Medical Research Stocks (ACCESSWIRE)

Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CHEK

Check-Cap Ltd

Upgrade your FINVIZ experience